Brief: Nanoform Signs Agreement With U.S. Biopharma Company

Nanoform Finland Oyj

12/05/2026 06:07

May 12 (Reuters) - Nanoform Finland Oyj NANOFH.HE:

CO SIGNS FIRST EXCLUSIVITY AGREEMENT FOR ULTRA-HIGH CONCENTRATION SUBCUTANEOUS DELIVERY

SIGNS FIRST EXCLUSIVITY AGREEMENT FOR BIOLOGICS TECHNOLOGY

MILESTONES UP TO HIGH TENS OF MLNS USD PLUS TIERED ROYALTIES AGREED

EXCLUSIVITY EXTENSION OPTION FOR ADDITIONAL USD 1 MILLION PAYMENT

Source text: ID:nMFN5F7Zy7

Further company coverage: NANOFH.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))